Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh

PURPOSE: Hyperinflammation in severe COVID-19 infection increases the risk of respiratory failure and one of the cogent reasons of mortality associated with COVID-19. Baricitinib, a janus kinases inhibitor, can potentially suppress inflammatory cascades in severe COVID-19 pneumonia. METHODS: The obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Md. Jahidul, Rabbani, Raihan, Anam, Ahmad Mursel, Huq, Shihan Mahmud Redwanul, Polash, Mohammad Mufizul Islam, Nessa, Shahzadi Sayeeda Tun, Bachar, Sitesh C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102838/
https://www.ncbi.nlm.nih.gov/pubmed/33962573
http://dx.doi.org/10.1186/s12879-021-06119-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102838/
https://www.ncbi.nlm.nih.gov/pubmed/33962573
http://dx.doi.org/10.1186/s12879-021-06119-2

Ejemplares similares